+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 19Years +
FEMALE
ID06704945

Phase III Trial Comparing No Axillary Surgery to Sentinel Lymph Node Biopsy in Women with Lymph Node Negative Breast Cancer After Chemotherapy

Led by Seoul National University Hospital · Updated on 2026-01-28

464

Participants Needed

1

Research Sites

260 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether skipping axillary lymph node surgery after neoadjuvant chemotherapy is as safe as performing sentinel lymph node biopsy SLNB in breast cancer patients who show no lymph node involvement on ultrasound. This phase III trial aims to understand if avoiding axillary surgery affects 5-year disease-free survival, building on previous studies that suggest some patients may not need this surgery to reduce complications without compromising outcomes. Participants will be randomly assigned to one of two groups. One group will have breast-conserving surgery BCS without any axillary surgery, while the other group will have BCS with SLNB, possibly including axillary lymph node dissection ALND. The study compares these approaches after patients complete neoadjuvant chemotherapy and shows no lymph node involvement on ultrasound. During the trial, participants will be monitored over five years for invasive disease-free survival, overall survival, distant metastasis-free survival, and rates of axillary and locoregional recurrence. Quality of life will also be assessed for one year. The study involves regular clinical evaluations, imaging, and questionnaires to track outcomes and safety, with the goal of minimizing unnecessary surgical procedures and related complications.

CONDITIONS

Brief Title

No Axillary Surgical Treatment in Clinically Lymph Node Negative Patients on Ultrasonography After Neoadjuvant Chemotherapy

Research Team

W

Wonshik Han, MD, PhD.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here